Skip to main content
. 2004 Feb;164(2):613–622. doi: 10.1016/S0002-9440(10)63150-1

Table 3.

Clinical Characteristics of the 152 DLBCL Patients Included in the Outcome Analysis

Age (mean, range) 58.4 (5–96)
Gender Female 47.6%
Male 52.4%
IPI 0–1 41.8%
2 27.1%
3 17.1%
4–5 14.1%
Follow-up (median) 60.9
Overall survival 5-year cumulative survival 59.8%
Failure Cured versus fatal/refractory disease 50.6%/49.4%
Failure-free survival 5-year cumulative survival 50.4%